Fact CheckerSign in

NCT05591105Completed

The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery

Post-operative Morphine Consumption in Obese Patients Undergoing Laparoscopic Bariatric Surgery Following Ketamina and Lidocaine Perfusion

Source: ClinicalTrials.gov · Last updated 3 Jul 2024

Brief summary (registry, in English)

The goal of this observational study is to evaluate the quality of postoperative analgesia in a group of obese patients schedule to bariatric surgery under TIVA Opiod-free after to receive lidocaine and ketamine perfusion. The main question it aims to answer are: How lidocaine and ketamine perfusion during recovery period does impact over morphine consumption on the following 48 hours after surgery? All participants will receive total intravenous anesthesia and, at the end of the surgery, they will be divided in two groups, group A: placebo and, group B: with postoperative lidocaine and ketamine perfusion. Our hypothesis is ketamine and lidocaine are a good alternative to decrease the use of morphine in obese patients.

Status (registry)
Completed
Study type
Observational
Enrollment
64 (actual)
First submitted
18 Oct 2022
Start date
15 Jun 2023
Primary completion date
30 Dec 2023
Lead sponsor
Tiva Group
Diseases
Obesity
NCT number
NCT05591105

What you commit to

  • Study type: Observational
  • Participants enrolled: 64
  • From 15 Jun 2023 to the primary completion date, 30 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Surgical complication

Other illness

  • Patients with allergies to any study medication.
  • Kidney or heptic failure.

Other

  • Patients taking high doses of opioids before operation for chronic pain
  • Pregnancy or breastfeeding.

Who the study is looking for

  • All patients between 18 y 65 years old.
  • IMC \> 30 kg/m2
  • ASA II/III

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Carolina
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.